• Suitable for damaged skin, scars.
  • Hypoallergenic. Non-comedogenic.
  • Free from fragrance and parabens.
Estimated Delivery Between 2022/01/23 - 2022/01/24


Photoderm spot contains glabridin: derived from a licorice extract, this molecule is known to biologically inhibit tyrosinase, a key enzyme in melanogenesis. Since melanin production is slowed down, photoderm spot prevents pigmentation marks and the hyperpigmentation of scars. Moreover, in addition to its surface UVA, UVB protective activity (filtering systems) photoderm spot offers real internal biological protection: cellular bio protection. This exclusive patent preserves and stimulates the skin’s defences (immunity) during sun exposure.

Protect skin with localised hyperpigmentation and sunspots with the Bioderma Photoderm Spot Cream SPF50+.

The formula is also suitable for skin that has been treated by laser, or scarred complexions. It offers maximum photoprotection with a wealth of specific active ingredients that minimise the risk of further pigmentation. The maximum anti-UVB protection and unrivalled, extreme anti-UVA performance protect the skin from sunburn, sun intolerance and premature ageing.

Created especially for facial skin, it guarantees optimum protection from the sun with its patented Cellular BIOprotection® complex. The melting texture of the cream leaves the skin feeling comforted and very soft.

How to Use

Apply Photoderm Spot generously before sun exposure, and reapply frequently. Colourless when applied, the cream leaves no oily film or white marks. Non-comedogenic, water-resistant, photostable and fragrance-free, Photoderm Spot ensures excellent tolerance.



Bioderma Laboratories is a privately owned French pharmaceutical company that specialises in medication for dermatological and hair/scalp conditions, as well as for Pediatry and cell regeneration.

Additional information

Weight 30 g
Dimensions 23 × 18 × 6 cm


There are no reviews yet.

Be the first to review “PHOTODERM SPOT CREAM SPF50+”

Your email address will not be published. Required fields are marked *